HYBRID EVENT: You can participate in person at Rome, Itlay or Virtually from your home or work.

11th Edition of International Conference on

Neurology and Neurological Disorders

June 05-07, 2025 | Rome, Italy

Muscular Dystrophy

Muscular Dystrophy

Muscular Dystrophy (MD) is a group of disorders that cause progressive weakening and wasting away of muscle tissue. The disease is caused by a mutation of a gene that controls production of dystrophin, which is an essential protein needed to develop and maintain healthy muscle fibers. Symptoms of MD vary depending on the type, but can include progressive muscle weakness, loss of muscle mass, difficulty in walking, difficulty with balance and coordination, and eventual loss of independent mobility. While there is no single form of treatment that can fully address every symptom of MD, there are a variety of medical interventions and treatments that can improve quality of life. Medication can help with pain management, while physical and occupational therapy can help improve strength, flexibility, coordination and balance. Assistive devices such as wheelchairs and walkers can increase mobility, and braces or casts can be used to manage joint contractures. Specialized breathing and swallowing therapies may also be helpful in some cases. In addition to medical and therapeutic interventions, lifestyle modifications can also improve quality of life. People with MD should strive to maintain a healthy weight and incorporate regular exercise into their daily life. Aerobic activities such as swimming, biking or walking, as well as strength-building activities can help to improve muscle strength and stamina. Eating a nutritious diet and avoiding alcohol and tobacco can also be beneficial. Overall, living with MD can be challenging. However, with proper monitoring, lifestyle modifications and medical treatments, individuals affected by the disorder can still lead full and active lives. Through research and scientific advancements, the outlook for those impacted by MD continues to improve and more effective treatment options become available.

Committee Members
Speaker at Neurology and Neurological Disorders 2025 - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute, Australia
Speaker at Neurology and Neurological Disorders 2025 - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
Speaker at Neurology and Neurological Disorders 2025 - Luiz Moutinho

Luiz Moutinho

University of Suffolk, United Kingdom
Neurology 2025 Speakers
Speaker at Neurology and Neurological Disorders 2025 - David Lominadze

David Lominadze

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Milton C R Medeiros

Milton C R Medeiros

Irmandade Santa Casa de Arapongas PR, Brazil
Speaker at Neurology and Neurological Disorders 2025 - Sang Hie Lee

Sang Hie Lee

University of South Florida, United States
Speaker at Neurology and Neurological Disorders 2025 - Sergei M Danilov

Sergei M Danilov

University of Illinois, United States

Submit your abstract Today

Watsapp